CSNK2B and breast carcinoma: As shown in Figure 6D, high expression of CSNK2B (p = 0.0041, HR = 1.37), GRPEL1 (p = 0.0200, HR = 1.29) and QARS (p = 0.0350, HR = 1.26) were corelated with worse prognosis in breast cancer patients, whereas CCND3, HDAC3, SH3BGRL3, SRM, and UBE2D4 were not correlated with OS.